JP2021536466A5 - - Google Patents

Info

Publication number
JP2021536466A5
JP2021536466A5 JP2021512652A JP2021512652A JP2021536466A5 JP 2021536466 A5 JP2021536466 A5 JP 2021536466A5 JP 2021512652 A JP2021512652 A JP 2021512652A JP 2021512652 A JP2021512652 A JP 2021512652A JP 2021536466 A5 JP2021536466 A5 JP 2021536466A5
Authority
JP
Japan
Prior art keywords
approximately
film according
activator
film
medium
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021512652A
Other languages
English (en)
Japanese (ja)
Other versions
JP2021536466A (ja
JP7637616B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2019/049725 external-priority patent/WO2020051317A1/en
Publication of JP2021536466A publication Critical patent/JP2021536466A/ja
Publication of JP2021536466A5 publication Critical patent/JP2021536466A5/ja
Priority to JP2025023573A priority Critical patent/JP2025093925A/ja
Application granted granted Critical
Publication of JP7637616B2 publication Critical patent/JP7637616B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021512652A 2018-09-07 2019-09-05 厳密な活性剤溶解プロファイルを有する口腔用フィルム組成物及び剤形 Active JP7637616B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2025023573A JP2025093925A (ja) 2018-09-07 2025-02-17 厳密な活性剤溶解プロファイルを有する口腔用フィルム組成物及び剤形

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201862728187P 2018-09-07 2018-09-07
US62/728,187 2018-09-07
US201862732720P 2018-09-18 2018-09-18
US62/732,720 2018-09-18
PCT/US2019/049725 WO2020051317A1 (en) 2018-09-07 2019-09-05 Oral film compositions and dosage forms having precise active dissolution profiles

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2025023573A Division JP2025093925A (ja) 2018-09-07 2025-02-17 厳密な活性剤溶解プロファイルを有する口腔用フィルム組成物及び剤形

Publications (3)

Publication Number Publication Date
JP2021536466A JP2021536466A (ja) 2021-12-27
JP2021536466A5 true JP2021536466A5 (cg-RX-API-DMAC10.html) 2022-09-13
JP7637616B2 JP7637616B2 (ja) 2025-02-28

Family

ID=68425244

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2021512652A Active JP7637616B2 (ja) 2018-09-07 2019-09-05 厳密な活性剤溶解プロファイルを有する口腔用フィルム組成物及び剤形
JP2025023573A Pending JP2025093925A (ja) 2018-09-07 2025-02-17 厳密な活性剤溶解プロファイルを有する口腔用フィルム組成物及び剤形

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2025023573A Pending JP2025093925A (ja) 2018-09-07 2025-02-17 厳密な活性剤溶解プロファイルを有する口腔用フィルム組成物及び剤形

Country Status (7)

Country Link
US (5) US11541002B2 (cg-RX-API-DMAC10.html)
EP (1) EP3846778A1 (cg-RX-API-DMAC10.html)
JP (2) JP7637616B2 (cg-RX-API-DMAC10.html)
CN (2) CN112955124A (cg-RX-API-DMAC10.html)
BR (1) BR112021004053A2 (cg-RX-API-DMAC10.html)
CA (1) CA3110997A1 (cg-RX-API-DMAC10.html)
WO (1) WO2020051317A1 (cg-RX-API-DMAC10.html)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20210346385A1 (en) * 2018-09-21 2021-11-11 MSB Holdings, Inc Taste-masked dosage forms
US11331309B2 (en) * 2019-06-05 2022-05-17 Cure Pharmaceutical Holding Corp. Methods and compositions for improving sleep
EP3895692A1 (en) * 2020-04-15 2021-10-20 LTS Lohmann Therapie-Systeme AG Oral thin film with smooth fused film
CN112697937A (zh) * 2020-12-18 2021-04-23 卓和药业集团有限公司 泊沙康唑肠溶片溶出度的分析方法
US20220347117A1 (en) * 2021-03-09 2022-11-03 Aquestive Therapeutics, Inc. Dosage forms having equivalent biocomparable profiles
CN113311124B (zh) * 2021-06-08 2023-11-14 湖南慧泽生物医药科技有限公司 模拟药剂在体释放及吸收过程的二室模型实验装置
CN115671078A (zh) * 2021-07-28 2023-02-03 上海博志研新药物技术有限公司 一种依匹斯汀口溶膜组合物、其制备方法及应用
CN114010575B (zh) * 2021-10-22 2024-06-28 江苏谛奇医药科技有限公司 新斯的明及其衍生物的新制剂
KR20240093850A (ko) * 2021-10-22 2024-06-24 어퀘스티브 테라퓨틱스, 아이엔씨. 개선된 안정성 프로파일을 갖는 약제학적 조성물
WO2023078366A1 (zh) * 2021-11-04 2023-05-11 上海博志研新药物技术有限公司 一种盐酸鲁拉西酮口溶膜组合物、其制备方法及应用
CN116211833A (zh) * 2021-11-30 2023-06-06 南京海辰药业股份有限公司 一种咪唑立宾口腔速溶膜剂及其制备方法
CN114983984B (zh) * 2022-07-26 2023-09-01 山东达因海洋生物制药股份有限公司 一种用于哮喘治疗复方口溶膜剂及其制备方法
CN119909044A (zh) * 2023-10-31 2025-05-02 浙江紫藤药业科技有限公司 一种口腔膜剂及其制备方法
JP7659339B1 (ja) 2023-11-21 2025-04-09 東海カプセル株式会社 ピモベンダンを含有する経口フィルム製剤
CN117414352A (zh) * 2023-11-22 2024-01-19 湖北广济医药科技有限公司 一种瑞美吉泮口溶膜剂及其制备方法
CN117631135B (zh) * 2024-01-25 2024-04-09 四川大学 一种双功能柔性水凝胶光纤及其制备方法和应用
CN118576571B (zh) * 2024-05-31 2025-02-14 浙江大学 一种药物释放曲线可定制的口服膜剂及其制备方法
WO2025261492A1 (zh) * 2024-06-20 2025-12-26 广州玻思韬控释药业有限公司 一种秋水仙碱膜剂
TW202604479A (zh) * 2024-06-26 2026-02-01 大陸商浙江同源康醫藥股份有限公司 依達拉奉口腔溶膜速釋製劑組合物及其製劑和用途
US20260027045A1 (en) * 2024-07-23 2026-01-29 Aquestive Therapeutics, Inc. Methods of administering enhanced delivery epinephrine and prodrug compositions
CN119139272A (zh) * 2024-09-02 2024-12-17 华中药业股份有限公司 一种艾司唑仑口腔速溶膜剂及其制备方法
CN118903065B (zh) * 2024-10-12 2025-02-07 山东则正医药技术有限公司 一种卢美哌隆口溶膜掩味组合物、其制备方法及应用
WO2026150511A1 (ja) * 2025-01-08 2026-07-16 東海カプセル株式会社 ピモベンダンを含有する経口フィルム製剤
CN119970685B (zh) * 2025-02-18 2025-10-14 杭州成邦医药科技有限公司 一种卢美哌隆或其盐的膜剂与其制备方法

Family Cites Families (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4631837A (en) 1985-05-31 1986-12-30 Magoon Richard E Method and apparatus for drying fruit pulp and the like
US6713471B1 (en) 1999-06-15 2004-03-30 Bristol-Myers Squibb Pharma Company Substituted heterocycle fused gamma-carbolines
US7071186B2 (en) 1999-06-15 2006-07-04 Bristol-Myers Squibb Pharma Co. Substituted heterocycle fused gamma-carbolines
WO2000077001A1 (en) 1999-06-15 2000-12-21 Du Pont Pharmaceuticals Company Substituted heterocycle fused gamma-carbolines
US20070281003A1 (en) 2001-10-12 2007-12-06 Fuisz Richard C Polymer-Based Films and Drug Delivery Systems Made Therefrom
US8603514B2 (en) 2002-04-11 2013-12-10 Monosol Rx, Llc Uniform films for rapid dissolve dosage form incorporating taste-masking compositions
US7666337B2 (en) 2002-04-11 2010-02-23 Monosol Rx, Llc Polyethylene oxide-based films and drug delivery systems made therefrom
US8900498B2 (en) 2001-10-12 2014-12-02 Monosol Rx, Llc Process for manufacturing a resulting multi-layer pharmaceutical film
US8765167B2 (en) 2001-10-12 2014-07-01 Monosol Rx, Llc Uniform films for rapid-dissolve dosage form incorporating anti-tacking compositions
US7357891B2 (en) 2001-10-12 2008-04-15 Monosol Rx, Llc Process for making an ingestible film
US7425292B2 (en) 2001-10-12 2008-09-16 Monosol Rx, Llc Thin film with non-self-aggregating uniform heterogeneity and drug delivery systems made therefrom
US8900497B2 (en) 2001-10-12 2014-12-02 Monosol Rx, Llc Process for making a film having a substantially uniform distribution of components
US8017150B2 (en) 2002-04-11 2011-09-13 Monosol Rx, Llc Polyethylene oxide-based films and drug delivery systems made therefrom
CA2516291C (en) 2003-02-28 2012-02-14 Alk-Abello A/S Dosage form having a saccharide matrix
US8012505B2 (en) * 2003-02-28 2011-09-06 Alk-Abello A/S Dosage form having a saccharide matrix
US7906140B2 (en) * 2004-06-17 2011-03-15 Virun, Inc. Compositions for mucosal delivery of agents
MX394214B (es) 2007-03-12 2025-03-24 Intra Cellular Therapies Inc Sintesis de gamma-carbolinas fusionadas con heterociclo substituido.
ES2530090T3 (es) 2008-03-12 2015-02-26 Intra-Cellular Therapies, Inc. Sólido de gamma-carbolinas fusionadas con heterociclo sustituido
CA2725342C (en) 2008-05-27 2024-02-20 Intra-Cellular Therapies, Inc. Substituted heterocycle fused gamma-carbolines for sleep disorders and other disorders
EP2448554A4 (en) 2009-06-29 2014-03-12 Oreal REFRESHING CREAM BASE IN YELLOW
WO2011053251A1 (en) 2009-10-30 2011-05-05 Ix Biopharma Pte Ltd Fast dissolving solid dosage form
US8956685B2 (en) 2010-02-24 2015-02-17 Monosol Rx, Llc Use of dams to improve yield in film processing
US8993572B2 (en) 2010-04-22 2015-03-31 Intra-Cellular Therapies, Inc. Pyrido[3′,4′:4,5]pyrrolo[1,2,3-de]quinoxalines derivatives and [1,4]oxazino[2,3,4-hi]pyrido[4,3-b]indole derivatives
CN108175762A (zh) 2010-09-23 2018-06-19 莫诺索尔克斯有限公司 用于直接在包装表面上形成药用产品的方法和系统
US11129799B2 (en) 2011-04-12 2021-09-28 Aquestive Therapeutics, Inc. Dual lane coating
US20130156823A1 (en) * 2011-12-20 2013-06-20 MAP Pharmacauticals, Inc. Excipient-free Aerosol Formulation
US9428506B2 (en) 2012-04-14 2016-08-30 Intra-Cellular Therapies, Inc. Substituted pyrido[3′,4′:4,5]pyrrolo[1,2,3-de]quinoxalines for the treatment of nervous system disorders
JP5952646B2 (ja) 2012-06-07 2016-07-13 救急薬品工業株式会社 口腔内溶解型フィルム製剤
WO2014145192A1 (en) 2013-03-15 2014-09-18 Intra-Cellular Therapies, Inc. Organic compounds
KR102967223B1 (ko) 2013-12-03 2026-05-19 인트라-셀룰라 써래피스, 인코퍼레이티드. 신규한 방법
US9745300B2 (en) 2014-04-04 2017-08-29 Intra-Cellular Therapies, Inc. Organic compounds
KR20220054908A (ko) 2014-04-04 2022-05-03 인트라-셀룰라 써래피스, 인코퍼레이티드. 유기 화합물
US10179776B2 (en) 2014-06-09 2019-01-15 Intra-Cellular Therapies, Inc. Compounds and methods of use to treat schizophrenia
CA2953546A1 (en) * 2014-06-24 2015-12-30 Taho Pharmaceuticals Fast acting orally disintegrating film
KR20170117374A (ko) * 2014-12-09 2017-10-23 모노졸 알엑스, 엘엘씨 선형 다당류-기반 필름 생성물
CN105193772A (zh) * 2015-10-28 2015-12-30 陈跃坚 一种沙格列汀口腔膜剂及其制备方法
CN122182527A (zh) * 2016-05-05 2026-06-12 阿奎斯蒂弗医疗股份有限公司 增强递送的肾上腺素组合物
EP3452024A1 (en) * 2016-05-05 2019-03-13 Aquestive Therapeutics, Inc. Pharmaceutical compositions with enhanced permeation

Similar Documents

Publication Publication Date Title
EP2717852B1 (en) Edible oral strip or wafer dosage form containing ion exchange resin for taste masking
ES2692890T3 (es) Formulaciones líquidas que comprenden un agente activo, glicerina y sorbitol
ES2706481T3 (es) Forma de dosificación en película oral humectable de forma instantánea sin tensioactivo o polialcohol
HU229394B1 (hu) Leheletfrissítõ film
WO2003063603A1 (en) Hard sugar coated preparations, sugar coating solutions and process for producing hard sugar coated preparation
WO2008018371A1 (fr) Comprimé à désagrégation orale ayant un goût amer masqué et son procédé de production
JP3631782B2 (ja) ウルソデオキシコール酸を含む液体投与形態の薬剤
JP6049624B2 (ja) 苦味のある薬物のための経口用医薬フィルム製剤
BRPI0709719A2 (pt) formas de dosagem sàlida revestidas de pelÍcula
CN1431874A (zh) 聚磷酸盐作为牙齿侵蚀抑制剂在酸性组合物中的用途
JP2016526914A (ja) タンパク質を含むマトリクス中にマイクロカプセル化風味料を含む、チューインガム組成物
BR112021016421A2 (pt) Minimização de aglomeração, aeração e preservação do revestimento de composições farmacêuticas que compreendem ibuprofeno
CN103763935B (zh) 可降解的咀嚼型胶基糖以及制作所述可降解的咀嚼型胶基糖的方法
KR100963051B1 (ko) 입자크기가 조절된 술포데히드로아비에트산을 함유한쓴맛이 저감된 경구용 액상 조성물
ES2793534T3 (es) Composición como medio auxiliar para medicación oral
LV11818B (en) Novel pharmaceutical composition for the preparation of a stable powder containing an active principle comprising an association of acetylsalicylic acid and metoclopramide
RU2016130051A (ru) Жидкие композиции рацекадотрила
HU219334B (en) Antacid composition and process for its production
US20190240187A1 (en) Oral preparations with omeprazole or pantoprazole
WO2006118137A1 (ja) ビグアナイド系薬物を含有する粒状製剤
CN115969820B (zh) 一种孟鲁司特钠口腔溶膜剂及其制备工艺
JP2009514857A5 (cg-RX-API-DMAC10.html)
HRP20220691T1 (hr) Poboljšanja u i u vezi s pripravcima
CN107007565A (zh) 一种盐酸鲁拉西酮口崩片及其制备方法
JP5009707B2 (ja) 不快な味がマスキングされたキノロン系抗菌剤の経口投与用液剤